Gujarat Kidney and Super Speciality MD, chairman and AGM
NSE: GKSLBSE: 544666Healthcare ServicesSmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹171.87.
30 Oct: open ₹171.90, high ₹172.58, low ₹160.84
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,288 Cr1,531st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.10
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Dec 2025
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.06
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,79,68846.6% delivered
Gujarat Kidney and Super Speciality's chairperson and managing director is Pragnesh Yashwantsinh Bharpoda, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 28 Sep 2026.
Gujarat Kidney and Super Speciality board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.
- Chairperson and managing directorPragnesh Yashwantsinh Bharpoda
8 directors5 independent2 executive1 non-executive
- Pragnesh Yashwantsinh Bharpoda · Chairperson and managing directorExecutive · joined Sep 2023 · reappointed Jan 2025 · 1 listed board · 1 committee seat
- Bhartiben Pragnesh BharpodaExecutive · joined Dec 2019 · reappointed Jan 2025 · 1 listed board
- Anitaben Yashvantsinh BharpodaNon-executive · joined Dec 2019 · 1 listed board
- Jagdishbhai Vinodchandra ThakkarIndependent · joined Dec 2024 · reappointed Dec 2024 · 21 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- Udayan Maheshkant KachchhiIndependent · joined Dec 2024 · reappointed Dec 2024 · 21 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- Kairavi Naimesh ShahIndependent · joined Dec 2024 · reappointed Dec 2024 · 21 months as independent · 1 listed board · 1 as independent · 2 committee seats
- Paresh DhotiIndependent · joined Jul 2026 · 2 months as independent · 1 listed board · 1 as independent
- Disha BharpodaIndependent · joined Aug 2026 · 1 month as independent · 1 listed board · 1 as independent
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 24 Aug 20267 of 7 present3 independent · 9 days in between
- 14 Aug 20266 of 7 present2 independent · 35 days in between
- 9 Jul 20265 of 6 present2 independent · 11 days in between
- 27 Jun 20266 of 6 present3 independent · 29 days in between
2 earlier meetings
- 28 May 20265 of 6 present2 independent · 30 days in between
- 27 Apr 20266 of 6 present3 independent
Audit Committee
Chair Jagdishbhai Vinodchandra Thakkar
Kairavi Naimesh Shah, Udayan Maheshkant Kachchhi, Pragnesh Yashwantsinh Bharpoda
- 24 Aug 20263 of 4 present2 independent · 9 days in between
- 14 Aug 20263 of 4 present2 independent · 35 days in between
- 9 Jul 20263 of 4 present2 independent · 11 days in between
- 27 Jun 20264 of 4 present3 independent · 29 days in between
1 earlier meeting
- 28 May 20264 of 4 present3 independent
Nomination and remuneration committee
Chair Kairavi Naimesh Shah
Udayan Maheshkant Kachchhi, Jagdishbhai Vinodchandra Thakkar
- 24 Aug 20263 of 3 present3 independent
- 14 Aug 20262 of 3 present2 independent · 35 days in between
- 9 Jul 20262 of 3 present2 independent · 41 days in between
- 28 May 20262 of 3 present2 independent
Stakeholders Relationship Committee
Chair Udayan Maheshkant Kachchhi
Kairavi Naimesh Shah, Jagdishbhai Vinodchandra Thakkar
No meeting listed in the filing.
Corporate Social Responsibility Committee
Chair Pragnesh Yashwantsinh Bharpoda
Jagdishbhai Vinodchandra Thakkar, Udayan Maheshkant Kachchhi
No meeting listed in the filing.
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Jun 2026.
- Y M Shah & CoPeer-review certificate valid to Jun 2027
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Gujarat Kidney and Super Speciality AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.
Annual general meeting, 28 Sep 2026
12,948 shareholders on the register on 21 Sep 2026; present: 5 promoters and 25 others; votes counted by Ashish Doshi / SPANJ & Associates.The company's voting result
- Adoption of Standalone and Consolidated Financial Statements for the FY 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Appointment of Mrs Anita Bharpoda (DIN:08644747) Director retiring by rotationOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Appointment of Secretarial AuditorOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Appointment of Mr Paresh Dhoti (DIN:10387032) as an Independent DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Appointment of Mrs Disha Bharpoda (DIN:11897794) as an Independent DirectorSpecial100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approval of Revision in Remuneration of Mr Pragnesh Bharpoda (DIN: 01033141), Managing DirectorSpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approval of Revision in Remuneration of Mrs. Bharti Bharpoda (DIN: 08644746), Wholetime DirectorSpecialPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approval under section 180 (1)(c) of the Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approval under section 180 (1)(a) of the Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approve increase in threshold of loans/ guarantees, providing of securities and making of investments in securities under section 186 of the Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approval to advance any loan/give guarantee/provide security under section 185 of the Companies Act, 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.44% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
- Approve related party transactionsOrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.36% · promoters 100.00% · institutions 3.62% · other public 3.03%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 22 Aug 2026, 1 resolution
13,678 shareholders on the register on 17 Jul 2026; votes counted by Ashish Doshi / SPANJ & Associates.The company's voting result
- To consider and approve Variation in the Objects / terms of utilisation of the Initial Public Offering (“IPO”) proceeds.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.35%
Turnout: all 72.17% · promoters 100.00% · institutions 1.09% · other public 2.93%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 4 Jul 2026, 1 resolution
14,279 shareholders on the register on 29 May 2026; votes counted by Ashish Doshi / SPANJ & Associates.The company's voting result
- Variation in the Objects / terms of utilisation of the Initial Public Offering (“IPO”) proceeds.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 72.16% · promoters 100.00% · institutions 0.90% · other public 3.00%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 25 Apr 2026, 3 resolutions
18,563 shareholders on the register on 20 Mar 2026; votes counted by Dharmendra Bhaliya / Dharmendra Bhaliya.The company's voting result
- To consider and approve the Interim utilisation of Funds towards healthcare expansion aligned with the Companys Main IPO object.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 72.10% · promoters 100.00% · institutions 0.00% · other public 2.89%
- To approve voluntary revision of Financial Statements and Boards report under section 131 of Companies Act 2013Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.03%
Turnout: all 72.10% · promoters 100.00% · institutions 0.00% · other public 2.89%
- To appoint Mr Dharmendra Bhaliya, Practising Company Secretary, as Secretarial Auditors of the Company for FY 2025-26Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.06%
Turnout: all 72.10% · promoters 100.00% · institutions 0.00% · other public 2.89%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.
Mutual fund votes, meeting of 28 Sep 2026, 2 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
- Adoption of Standalone and Consolidated Financial Statements for the FY 2025-26
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundUnqualified financial statements (except non-material observations in CARO report). Compliant with Indian Accounting Standards. NonCompliant with the Companies Act, 2013 & SEBI LODR Regulations: Non-disclosure of financial statements for all Subsidiary Companies on the website of the Company for FY 2025-26.
0 for2 against - Appointment of Mrs Anita Bharpoda (DIN:08644747) Director retiring by rotation2 for0 against
- Appointment of Secretarial Auditor
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundNo concern on the merits of the proposed Auditors. Transparency Concern: Remuneration of outgoing auditor not disclosed; thus, SES is unable to ascertain whether there is any material change in the proposed audit fee.
0 for2 against - Appointment of Mr Paresh Dhoti (DIN:10387032) as an Independent Director2 for0 against
- Appointment of Mrs Disha Bharpoda (DIN:11897794) as an Independent Director2 for0 against
- Approval of Revision in Remuneration of Mr Pragnesh Bharpoda (DIN: 01033141), Managing Director2 for0 against
- Approval of Revision in Remuneration of Mrs. Bharti Bharpoda (DIN: 08644746), Wholetime Director2 for0 against
- Approve increase in threshold of loans/ guarantees, providing of securities and making of investments in securities under section 186 of the Companies Act, 2013
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with the law. Governance & Transparency Concern: Lack of adequate disclosure as the Company has not provided details of the recipients. Umbrella / Blanket approval proposed to cover any person/entity in the proposed limit.
0 for2 against - Approval to advance any loan/give guarantee/provide security under section 185 of the Companies Act, 2013
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundNon-Compliant with Section 185 of the Companies Act: Inadequate disclosures w.r.t. the particulars mandated u/s 185 of Companies Act, 2013. Governance Concern: Enabling Approval with Inadequate disclosures – Generic justification and non-disclosure of the recipient(s) of the investments, loans, guarantees and security.
0 for2 against - Approve related party transactions2 for0 against
2 proposals not matched to one resolution
To borrow any sum or sums of money by obtaining loans, overdraft facilities, lines of credit, commercial papers, convertible/ nonconvertible debentures, external commercial borrowings (loans/bonds), INR denominated offshore bonds or in any other forms from Banks, Financial Institutions, other Bodies Corporate or other eligible investors, from time to time, which, together with the monies already borrowed by the Company (apart from temporary loans obtained or to be obtained from the Company’s Bankers in the ordinary course of business) may exceed, at any time, the aggregate of the paid-up share capital and free reserves, provided that the total amount so borrowed by the Board shall not at any time exceed Rs. 500 Crores or equivalent amount in any other foreign currency.MoreLess
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance and Transparency concern: Proposed borrowing limit is significantly high as compared to the Company’s current borrowings and financial position; Inadequate justification provided for the proposed limit.
0 for2 againstTo sell, lease or dispose of in any manner including but not limited to mortgaging, hypothecating, pledging or in any manner creating charge on all or any part of the present and future moveable or immovable assets or properties of the Company or the whole or any part of the undertaking(s) of the Company of every nature and kind whatsoever (hereinafter referred to as the Assets) and/or creating a floating charge on the Assets to or in favour of banks, financial institutions, investors, or any other lenders to secure the amount borrowed by the company or any entity which is a subsidiary or associate or group entity, from time to time, for the due re-payment of principal and/or together with interest, charges, costs, expenses and all other monies payable by the Company or any such entity in respect of the such borrowings provided that the aggregate indebtedness so secured by the assets do not at any time exceed Rs 500 Cr over and above the paid up capital of the Company and its free reserves.MoreLess
Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
- Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance and Transparency concern: Interlinked with #8, further, the charge creation limit is linked to the borrowing limit of the Company. Since governance and transparency concerns are identified with the resolution seeking borrowing limit, concerns are also identified with the proposed approval sought for the charge creation limit.
0 for2 against
Mutual fund votes, meeting of 22 Aug 2026, 2 fund houses
- To consider and approve Variation in the Objects / terms of utilisation of the Initial Public Offering (“IPO”) proceeds.2 for0 against
Mutual fund votes, meeting of 4 Jul 2026, 2 fund houses
1 proposal
- Variation in the Objects / terms of utilisation of the Initial Public Offering (“IPO”) proceeds.2 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Stakes in unlisted companies
Reported in the filing for the quarter to Sep 2026.
- Unlisted stake boughtBlue Tree Clinics, UAE DubaiSince 2 Sep 2026
51.00% bought in the quarter; holding 51.00%, from 0.00%
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Proposed acquisition of “Parekhs Hospital Private Limited” at Ahmedabad | 77.00 | 77.00 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Part payment of purchase consideration for the already acquired hospital i.e. “Ashwini Medical Centre | 12.40 | 12.40 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Acquisition of additional shareholding in our subsidiary namely “Harmony Medicare Private Limited” at Bharuch | 10.78 | 10.78 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Healthcare expansion aligned with the company’s main IPO object, including development and operation of Mult speciality hospital project in Bharuch through a newly incorporated private company | 25.15 | 4.95 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Setting up and Operating Dialysis services through deployment of Dialysis machine and Digital patient Monitoring solution by way of collaborating with Lord’s Mark Industries Limited | 6.83 | 6.83 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by our Company | 1.20 | 1.20 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | Funding inorganic growth through unidentified acquisitions and General Corporate Purposes. | 87.44 | 74.82 | Yes |
| Public IssuesDec 2025, checked by Brickwork ratings India Private Limited | 250.80 | issue expenses | 25.05 | 24.63 | Yes |